Frank A. D'Amelio's most recent trade in Hewlett Packard Enterprise Co was a trade of 14,499 Common Stock done at an average price of $24.0 . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hewlett Packard | Frank A. D’Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.98 per share. | 01 Apr 2026 | 14,499 | 47,490 (0%) | 0% | 24.0 | 347,687 | Common Stock |
| Hewlett Packard | Frank A. D’Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 14,499 | 0 | - | - | Restricted Stock Units | |
| Zoetis (Class A) | Frank A. D’Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2026 | 1,619 | 0 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Frank A. D’Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 1,619 | 11,620 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | Frank A. D’Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 1,936 | 1,936 | - | - | Restricted Stock Unit | |
| Humana | Frank A. D’Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 766 | 26,826 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 14,235 | 14,235 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Apr 2025 | 14,322 | 0 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.12 per share. | 02 Apr 2025 | 14,322 | 32,148 (0%) | 0% | 16.1 | 230,887 | Common Stock |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 1,596 | 1,596 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2025 | 1,225 | 9,857 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,225 | 0 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 1,236 | 8,632 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,236 | 0 | - | - | Restricted Stock Unit | |
| Humana | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 783 | 26,060 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 14,068 | 14,068 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 17,389 | 17,389 (0%) | 0% | 0 | Common Stock | |
| Hewlett Packard | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 17,389 | 0 | - | - | Restricted Stock Units | |
| Zoetis (Class A) | A. Frank D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2024 | 1,463 | 7,316 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | Frank D'Amelio A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,463 | 1,212 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | D'Amelio A. Frank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,493 | 0 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | D'Amelio A. Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,493 | 5,853 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | A. Frank D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,223 | 1,223 | - | - | Restricted Stock Unit | |
| Humana | D'Amelio Frank A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 430 | 430 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 17,010 | 17,010 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 3,444 | 0 | - | - | Restricted Stock Units | |
| Hewlett Packard | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 3,444 | 3,444 (0%) | 0% | 0 | Common Stock | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 1,626 | 2,651 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2023 | 1,626 | 4,321 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 1,480 | 1,480 | - | - | Restricted Stock Unit | |
| Hewlett Packard | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 3,444 | 3,444 | - | - | Restricted Stock Units | |
| Humana | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 380 | - | - | Restricted Stock Units | |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 127,160 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.60 per share. | 26 Feb 2022 | 127,160 | 649,918 (0%) | 0% | 25.6 | 3,255,296 | Common Stock |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.64 per share. | 26 Feb 2022 | 59,370 | 555,941 (0%) | 0% | 50.6 | 3,006,497 | Common Stock |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.72 per share. | 26 Feb 2022 | 34,607 | 615,311 (0%) | 0% | 47.7 | 1,651,446 | Common Stock |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 153,789 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2022 | 153,789 | 636,977 (0%) | 0% | 27.3 | 4,204,591 | Common Stock |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 126,794 | 126,794 | - | - | Stock Appreciation Rights | |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 111,516 | 111,516 | - | - | Stock Appreciation Rights | |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 23 Feb 2022 | 76,120 | 522,758 (0%) | 0% | 51.3 | 3,903,434 | Common Stock |
| Pfizer | Frank A. D'Amelio | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.87 per share. | 23 Feb 2022 | 38,099 | 598,878 (0%) | 0% | 46.9 | 1,785,700 | Common Stock |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 2,673 | 2,673 | - | - | Deferred Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 2,673 | 4,244 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 1,192 | 6,917 | - | - | Restricted Stock Unit | |
| Humana | Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 412 | 412 | - | - | Restricted Stock Units |